The introduction of biologic drugs revolutionized the treatment of psoriasis, shifting treatment
goals to higher treatment outcomes and less frequent safety issues. The outbreak of …

Introduction The various cutaneous manifestations have lately appeared in the setting of
COVID‐19. Psoriasis flare‐ups have been reported during a COVID‐19 infection. Case …

Despite the association of prevalent health conditions with coronavirus disease 2019
(COVID-19) severity, the disease-modifying biomolecules and their pathogenetic …

Psoriasis is a chronic inflammatory skin disease which is identified by the appearance of
erythematous that is clearly demarcated, scaly plaques. It is a skin disease seen regularly …

Introduction Chronic spontaneous urticaria (CSU) is defined as recurrent attacks of urticaria
present for more than six weeks. The monoclonal anti‐immunoglobulin E antibody …

Behçet's disease is a disease characterized by chronic inflammatory vasculitis. In the clinical
symptoms of Behçet's disease, many immunosuppressive and immunomodulatory drugs are …

SARS‐CoV‐2 and guttate psoriasis: A case report and review of literature - PMC Back to Top
Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main …

SARS‐CoV2 vaccines were approved without long‐term monitoring due to emergent
situations. This has raised some issues about timing and protocol of receiving vaccines in …

The COVID‐19 pandemic has been extra challenging for patients with chronic diseases.
Psoriasis is one of the chronic conditions that its treatment mostly relies on …

Background and Objectives: Atopic dermatitis (AD) is a disease with a complex
pathophysiology involving immune-mediated reactions that lead to skin lesions that are …